NRAS and melanoma: Overall, EPHB6G404S mutations were more frequently observed in melanomas without BRAF or NRAS mutations (16/202 melanomas, 7.9%), than co-occurring with either BRAF or NRAS mutations (10/264 melanomas, 3.8%, p-value = 0.04).